sulfasalazine has been researched along with Cancer of Endometrium in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, the role of ferroptosis in endometrial cancer treatment remains to be discussed." | 1.91 | Medroxyprogesterone acetate-resistant endometrial cancer cells are susceptible to ferroptosis inducers. ( Hayashi, M; Murakami, H; Ohmichi, M; Terada, S, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murakami, H | 1 |
| Hayashi, M | 1 |
| Terada, S | 1 |
| Ohmichi, M | 1 |
1 other study available for sulfasalazine and Cancer of Endometrium
| Article | Year |
|---|---|
Medroxyprogesterone acetate-resistant endometrial cancer cells are susceptible to ferroptosis inducers.
Topics: Endometrial Neoplasms; Female; Ferroptosis; Humans; Medroxyprogesterone Acetate; Reactive Oxygen Spe | 2023 |